The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Marc D. Schwartz

Department of Oncology

Cancer Control Program

Jess and Mildred Fisher Center for Familial Cancer Research

Lombardi Comprehensive Cancer Center

USA

[email]@georgetown.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Oncology, Cancer Control Program, Jess and Mildred Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, USA. 2012
  • Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. 2001 - 2009
  • Lombardi Cancer Center and Georgetown University School of Medicine, Washington, District of Columbia, USA. 2003

References

  1. Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance. Schwartz, M.D., Isaacs, C., Graves, K.D., Poggi, E., Peshkin, B.N., Gell, C., Finch, C., Kelly, S., Taylor, K.L., Perley, L. Cancer (2012) [Pubmed]
  2. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction. Schwartz, M.D., Valdimarsdottir, H.B., DeMarco, T.A., Peshkin, B.N., Lawrence, W., Rispoli, J., Brown, K., Isaacs, C., O'Neill, S., Shelby, R., Grumet, S.C., McGovern, M.M., Garnett, S., Bremer, H., Leaman, S., O'Mara, K., Kelleher, S., Komaridis, K. Health. Psychol (2009) [Pubmed]
  3. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Schwartz, M.D., Lerman, C., Brogan, B., Peshkin, B.N., Isaacs, C., DeMarco, T., Halbert, C.H., Pennanen, M., Finch, C. Cancer Epidemiol. Biomarkers Prev. (2005) [Pubmed]
  4. Decision making and decision support for hereditary breast-ovarian cancer susceptibility. Schwartz, M.D., Peshkin, B.N., Tercyak, K.P., Taylor, K.L., Valdimarsdottir, H. Health. Psychol (2005) [Pubmed]
  5. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. Schwartz, M.D., Lerman, C., Brogan, B., Peshkin, B.N., Halbert, C.H., DeMarco, T., Lawrence, W., Main, D., Finch, C., Magnant, C., Pennanen, M., Tsangaris, T., Willey, S., Isaacs, C. J. Clin. Oncol. (2004) [Pubmed]
  6. Prospective association between distress and mammography utilization among women with a family history of breast cancer. Schwartz, M.D., Taylor, K.L., Willard, K.S. J. Behav. Med (2003) [Pubmed]
  7. Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. Schwartz, M.D., Kaufman, E., Peshkin, B.N., Isaacs, C., Hughes, C., DeMarco, T., Finch, C., Lerman, C. J. Clin. Oncol. (2003) [Pubmed]
  8. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. Schwartz, M.D., Peshkin, B.N., Hughes, C., Main, D., Isaacs, C., Lerman, C. J. Clin. Oncol. (2002) [Pubmed]
  9. Consent to the use of stored DNA for genetics research: a survey of attitudes in the Jewish population. Schwartz, M.D., Rothenberg, K., Joseph, L., Benkendorf, J., Lerman, C. Am. J. Med. Genet. (2001) [Pubmed]
  10. Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women. Schwartz, M.D., Benkendorf, J., Lerman, C., Isaacs, C., Ryan-Robertson, A., Johnson, L. Cancer (2001) [Pubmed]
 
WikiGenes - Universities